SignalXSignalX

HAE HAEMONETICS CORP

8-K Current Report
Filed: March 3, 2026
Health Care
Surgical & Medical Instruments & Apparatus
HAEMONETICS CORP Overview

HAEMONETICS CORP (HAE) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 7.01 · Regulation FD Disclosure

  • • Reg FD disclosure signed by CFO James C. D'Arecca on March 3, 2026 — substantive disclosed content contained in referenced exhibit
  • • No financial figures or operational details present in the filing text itself; investor impact depends on exhibit content

Get deeper insights on HAEMONETICS CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.